Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03WDY
|
|||
| Former ID |
DNC007414
|
|||
| Drug Name |
N-(1,3,4-thiadiazol-2-yl)benzamide
|
|||
| Synonyms |
N-(1,3,4-Thiadiazol-2-yl)benzamide; RWOUBULBQYRRNL-UHFFFAOYSA-N; N-1,3,4-thiadiazol-2-yl-benzamide; 26861-95-0; BAS 03031913; AC1LC4SO; TimTec1_007967; CHEMBL390098; SCHEMBL3379803; CTK0I5904; DTXSID40341040; MolPort-001-017-069; HMS1556K03; ZINC892651; STK158583; AKOS000646792; MCULE-9389828263; N-[1,3,4]Thiadiazol-2-yl-benzamide; IDI1_033621; Benzamide, N-1,3,4-thiadiazol-2-yl-; N-([1,3,4]thiadiazol-2-yl)-benzamide; N~1~-(1,3,4-thiadiazol-2-yl)benzamide; ST50015221; phenyl-N-(1,3,4-thiadiazol-2-yl)carboxamide; SR-01000365353
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H7N3OS
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C(=O)NC2=NN=CS2
|
|||
| InChI |
1S/C9H7N3OS/c13-8(7-4-2-1-3-5-7)11-9-12-10-6-14-9/h1-6H,(H,11,12,13)
|
|||
| InChIKey |
RWOUBULBQYRRNL-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 26861-95-0
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | LOX-5 messenger RNA (ALOX5 mRNA) | Target Info | Inhibitor | [1] |
| BioCyc | Aspirin-triggered lipoxin biosynthesis | |||
| Resolvin D biosynthesis | ||||
| Leukotriene biosynthesis | ||||
| Lipoxin biosynthesis | ||||
| Aspirin triggered resolvin D biosynthesis | ||||
| Aspirin triggered resolvin E biosynthesis | ||||
| KEGG Pathway | Arachidonic acid metabolism | |||
| Metabolic pathways | ||||
| Serotonergic synapse | ||||
| Ovarian steroidogenesis | ||||
| Toxoplasmosis | ||||
| NetPath Pathway | IL4 Signaling Pathway | |||
| Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
| WikiPathways | Arachidonic acid metabolism | |||
| Eicosanoid Synthesis | ||||
| Selenium Micronutrient Network | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. J Med Chem. 2007 May 31;50(11):2640-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.